FRANKLIN RESOURCES INC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$81,769,125
+16.5%
54,750,0000.0%0.04%
+27.3%
Q2 2023$70,216,875
-5.1%
54,750,0000.0%0.03%
-10.8%
Q1 2023$73,994,625
-14.8%
54,750,0000.0%0.04%
-17.8%
Q4 2022$86,860,875
+12.3%
54,750,0000.0%0.04%
+7.1%
Q3 2022$77,362,000
+6.4%
54,750,0000.0%0.04%
+16.7%
Q2 2022$72,681,000
+0.6%
54,750,0000.0%0.04%
+24.1%
Q1 2022$72,270,000
+5.0%
54,750,0000.0%0.03%
+16.0%
Q4 2021$68,814,000
-5.9%
54,750,0000.0%0.02%
-10.7%
Q3 2021$73,136,000
-0.8%
54,750,0000.0%0.03%0.0%
Q2 2021$73,743,000
-0.6%
54,750,0000.0%0.03%
-6.7%
Q1 2021$74,152,000
-2.5%
54,750,0000.0%0.03%
-6.2%
Q4 2020$76,090,000
+0.3%
54,750,0000.0%0.03%
-13.5%
Q3 2020$75,829,000
-21.9%
54,750,0000.0%0.04%
-26.0%
Q2 2020$97,147,000
+37.9%
54,750,0000.0%0.05%
+6.4%
Q1 2020$70,437,000
-16.3%
54,750,0000.0%0.05%
+6.8%
Q4 2019$84,112,000
+12.0%
54,750,0000.0%0.04%
+7.3%
Q3 2019$75,101,000
+6.1%
54,750,000
+1.9%
0.04%
+7.9%
Q2 2019$70,789,000
+4.2%
53,750,000
+7.1%
0.04%
+5.6%
Q1 2019$67,964,000
+13.2%
50,200,0000.0%0.04%0.0%
Q4 2018$60,051,000
-26.4%
50,200,000
+5.0%
0.04%
-12.2%
Q3 2018$81,598,000
+20.6%
47,800,000
+2.1%
0.04%
+17.1%
Q2 2018$67,660,00046,800,0000.04%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders